Long acting, injectable regimens open the door to potential improvement in adherence through not only eliminating the need to take oral pills, but also reducing the self-stigmatization and disclosure concerns that patients with HIV may have.

People with type 1 and type 2 diabetes on insulin and a maximally tolerated statin, significantly reduced their
LDL cholesterol levels with alirocumab.

As of 2020, diabetes effects one in ten or 34.2 million Americans. One in three or 88 million
Americans are on their way to developing diabetes and are classified as having pre-diabetes.

Mental illness has long been stigmatized in this country and abroad. However, by transforming your perceptions of the mentally ill, becoming more informed about treatment of common mental illnesses such as generalized anxiety disorder and depression, improving your health literacy and verbiage when talking to patients, and using screening tools such as PHQ 2 or 9, clinicians can greatly improve health outcomes.

Participants will be able to
• Describe the differences between an
anticoagulant and an antiplatelet medication.
• Identify available agents and describe their
indications and pertinent clinical considerations
for drug selection.